Related Experiment Video
Updated: Jul 10, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease
Jon L Belsher1, Peter Gay, Margo Brinton
1Mayo Clinic College of Medicine, Rochester, MN, United States.
Abstract:
Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) is a rare complication of yellow fever (YF) vaccination. A previously healthy 22-year-old female died following YF vaccination despite aggressive measures. Serial viral load titers, cytokine levels and host genetic factors were evaluated in an attempt to understand this unusual and lethal outcome. The patient's high-titer vaccine viremia and possibly related minor genetic anomalies provide clues to exploring the etiology of YEL-AVD.
Related Concept Videos
Yellow Fever
Viral Hepatitis I: Introduction
Rocky Mountain Spotted Fever
Diphtheria
Vaccinations
Cross-reactivity

